EU Off-Patent Industry Sees ‘Limited Immediate Risk’ From COVID-19

But Coronavirus Could Have ‘Important Impact’ If Situation Continues

 
• By David Wallace
  
Mask
Medicines for Europe sees a limited immediate risk from the coronavirus outbreak, but the situation could worsen • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business